BioFactura, Inc.

BioFactura, Inc.

Biotechnology Research

Frederick, MD 1,810 followers

About us

BioFactura develops and commercializes biodefense drugs, novel drugs, and high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast™ Biomanufacturing Platform, the optimal choice for bringing these products to market with faster, lower cost, superior-quality manufacture. For over 10 years, BioFactura has been advancing life-saving medicines from the research bench to the patient using its innovative drug development and manufacturing technologies. Current and past programs include biodefense drugs against smallpox and Ebola, novel medicines for cancer, and low-cost/high-quality biosimilars for autoimmune and infectious diseases.

Website
http://www.biofactura.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Frederick, MD
Type
Privately Held
Founded
2003
Specialties
Cell Line Development, Bioprocess Design and Development, Monoclonal Antibody Drug Discovery, and Preclinical Biologics Manufacturing

Locations

Employees at BioFactura, Inc.

Updates

Similar pages

Browse jobs

Funding

BioFactura, Inc. 4 total rounds

Last Round

Grant

US$ 1.0M

See more info on crunchbase